Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

New genetic mutations causing hair loss were found in a Chinese family.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

The study found that Tourette Syndrome may be linked to certain immune system processes and synaptic signaling.

Keratosis pilaris causes small skin bumps, mainly in women, and treatments offer only temporary relief.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

New genes linked to male pattern baldness were found on chromosome 20p11.

Precise objectives can improve student achievement in health education.

Female-pattern hair loss can be diagnosed with trichoscopy and treated with nutrition, external therapies, and physiotherapy.

Recognizing keratosis pilaris in all skin tones helps diagnose related skin issues and reduce distress.

Björnstad syndrome can cause hair loss similar to androgenetic alopecia, and treatment with baricitinib and minoxidil may help.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

A new genetic model may improve treatment and diagnosis for certain inherited skin diseases.

Genetic defects in the Wnt/PCP pathway may cause congenital yellow nail syndrome.

An extremely low-birthweight infant had a rare genetic skin disease and died despite treatment.

Genetic and lifestyle factors influence skin and hair aging, and prediction models can help assess aging and cosmetic treatments.

Genetic factors may influence how well valproic acid works and its side effects in epilepsy treatment.

Alopecia areata is often linked to personal or family history of allergies and autoimmune diseases.

New mutations in MBTPS2 reduce its function and cause IFAP syndrome with unusual symptoms.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Lichen planus pigmentosus mainly affects middle-aged women with darker skin, is underreported, and is hard to treat.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

Non-classical 21-hydroxylase deficiency can be missed in newborn screenings and should be considered in cases of early puberty or virilization.

The research provided new insights into the genetic factors contributing to hair loss and skin conditions by analyzing individual cells from the human scalp.